syngeneic t lymphocytes
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02315118)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- syngeneic t lymphocytes
- t-cells rituximab + il-2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02315118 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2014 | National University of Singapore, Singapore General Hospital |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National University of Singapore | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Singapore General Hospital | Academic/Hospital | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1